Concordancia diagnóstica entre dos métodos de detección de hemoglobina glucosilada A1c en Atención Primaria

  1. Villar del Campo, M.ª Concepción
  2. Rodríguez Caravaca, Gil
  3. Gil Yonte, Pablo Luis
  4. Cidoncha-Calderón, E.
  5. García-Cruces Méndez, J.
  6. Donnay-Pérez, S.
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2014

Issue: 8

Pages: 431-435

Type: Article

DOI: 10.1016/J.SEMERG.2014.01.012 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

Objective. Several methods are available for measuring glycosylated A1c hemoglobin (HbA1c), all rapid methods for point of care use in a clinical or laboratory setting. This study attempts to compare the diagnostic agreement between two methods for detection of HbA1c. Material and methods. A descriptive cross-sectional study of diagnostic agreement was carried out in the Los Carmenes Health Centre. Two groups of patients -with and without type 2 diabetes- were consecutively included. A method for point-of-care use in a Primary Care Clinic setting (DCATM Systems Siemens®) was compared with a laboratory test (chromatographic analysis). An analysis was made of the mean concentration of HbA1c, the agreement between methods, using the intra-class correlation coefficient (CCLA1) and the Bland-Altman method. Results. A total of 102 patients were included, 62 diabetic (60.8%) and 40 non-diabetic (39.2%). The overall mean HbA1c was 6.46% (SD = 0.88) in the analysis using capillary blood in the clinic with the DCA� system, and 6.44% (SD = 0.86) using the laboratory test (P>.05). The degree of agreement between the two tests was 0.975 (95% CI: 0.963-0.983). The mean of the differences between the results of the two assessed tests was 0.024 (SD = 0.27). The percentage of points outside the limits of optimal agreement, as defined in the Bland-Altman graph, was 2.5%. Conclusions. Diagnostic agreement between a method for point-of-care use in a Primary Health Care Clinic and a laboratory test was very high. Detection at the point-of-care allows a quick and simple assessment of HbA1c.